Chicago, IL — The JAMA Network announces the launch of JAMA+ Trials, an interdisciplinary platform designed to elevate the visibility, accessibility, and understanding of trusted clinical trial research across medicine.
Alison J. Huang, M.D., M.A.S., Professor of Medicine, Urology, and Epidemiology & Biostatistics at the University of California, San Francisco, and Director of Research in the Division of General Internal Medicine at UCSF Health, serves as Editor in Chief of JAMA+ Trials.
A clinical epidemiologist and trialist, Dr. Huang’s research focuses on improving aging women’s and genitourinary health. She has led multiple NIH-, industry-, and foundation-funded randomized trials, developed widely used patient-reported outcome measures, and directs NIH-funded research training programs. She also teaches clinical research and trial methods at UCSF.
Alison J. Huang, M.D., M.A.S., leads JAMA+ Trials as Editor in Chief
“By fostering honest dialogue about the challenges trials face and the transformative evidence they produce, we seek to enhance professional and public understanding of, and ultimately trust in, the clinical trial enterprise,” said Dr. Huang.
READ: “A Love Letter to Clinical Trials”
JAMA+ Trials is designed not only for clinical trialists, but also for clinicians, patients, students, and policymakers.
The initiative includes:
- A searchable collection of recent trial reports from the 13 JAMA Network journals
- Tailored educational resources on trial design, conduct, and reporting, including new multimedia features
- Conversation and debate on how best to translate trial evidence into real-world practice
- Theme of the Month, including the inaugural theme: Virtual and Remotely Conducted Trials: Connection Without Contact
JAMA+ Trials will showcase the rigor, innovation, and real-world impact of the clinical trial enterprise while creating space for thoughtful dialogue about its challenges and opportunities.
“Trials are foundational to everything we do as a network of medical journals,” said Kirsten Bibbins-Domingo, M.D., Ph.D., M.A.S., Editor in Chief of JAMA and the JAMA Network. “We have invested heavily in educating readers about trial methodology, and I’m particularly excited about JAMA+ Trials because it builds on that work and moves it forward in a meaningful way.”
Visit JAMA+ Trials, where readers can sign up for Dr. Huang’s email newsletter, watch new videos, and download resources.
For additional editor curation around interdisciplinary topics shaping the future of medicine, check out JAMA+ AI and JAMA+ Women’s Health.
For more information, including requests for interviews with Dr. Huang, contact JAMA Network Media Relations at 312-464-JAMA (5252) or by email.
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5252) or email media relations.